Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI
Conditions: Diabetes Mellitus, Type 2; Coronary Artery Disease Interventions: Drug: Ticagrelor; Drug: Clopidogrel Sponsors: University of Florida; AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials